MedTrace Logo

Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis

NCT00862654 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 326

Last updated 2021-02-18

Study results available
· View outcomes & findings →

Summary

The objective is to assess different treatment regimens with Clobetasol propionate shampoo 0.05% in the treatment of scalp Seborrheic Dermatitis.

Conditions

  • Scalp Seborrheic Dermatitis

Interventions

DRUG

clobetasol propionate shampoo (4/week) - ketoconazole shampoo (2/week)

Association: clobetasol propionate shampoo \& ketoconazole shampoo

DRUG

clobetasol propionate shampoo (2/week) - ketoconazole shampoo (2/week)

Association: clobetasol propionate shampoo \& ketoconazole shampoo

DRUG

clobetasol propionate shampoo (2/week)

Monotherapy with clobetasol propionate shampoo

DRUG

ketoconazole shampoo (2/week)

Monotherpay ketoconazole shampoo (2/week)

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Jean-Paul Ortonne, MD · Nice Hospital (France)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Belgium
  • France
  • Germany
  • Mexico
  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00862654 on ClinicalTrials.gov